US 6204000
Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1
expired A61PA61P35/00A61P35/04
Quick answer
US patent 6204000 (Diagnostic methods and gene therapy using reagents derived from the human metastasis suppressor gene KAI1) held by The United States of America, as represented by the Department of Health and Human Services expires Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.
Key facts
- Applicant
- The United States of America, as represented by the Department of Health and Human Services
- Grant date
- Tue Mar 20 2001 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon Mar 15 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 7
- CPC classes
- A61P, A61P35/00, A61P35/04